Novocure
Martin Madden has been a director of Novocure since 2017. Mr. Madden retired after a 30-year career at Johnson & Johnson (from 1986 to 2017), where he most recently served as Vice President of R&D for DePuy-Synthes and Vice President of Medical Device R&D Transformation from February 2016 to January 2017; as Vice President of New Product Development, Medical Devices from July 2015 to February 2016; and as Vice President of R&D for the Global Surgery Group from January 2012 to July 2015. Earlier in his career, Mr. Madden was a medical device engineer and innovator and a leader of cross-functional teams charged with incubating, developing, and launching new products. He also serves on the board of Microbot Medical Inc. Mr. Madden graduated summa cum laude with a Bachelor’s degree in Mechanical Engineering from the University of Dayton, earned a Master’s degree with honors in Mechanical Engineering from Carnegie-Mellon University, and graduated first in his class with honors from Columbia University’s M.B.A. program.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.